1. The mRNA vaccine for the treatment of pancreatic cancer is here to stay. Chuluyan E, Davio C, Dusetti N, Fraunhoffer N, Garcia MN, Garona J, González B, Gottardo F, Grasso D, Iovanna J, Kohan G, Lada PE, Mazza O, Monte M, Papademetrio D, Pasqualini ME, Sahores A, Santofimia P, Yaneff A. Medicina (B Aires). 2023;83(4):650-652.
    2. Polyelectrolyte complexes hydrogels based on chitosan/pectin/NaCl for potentially wound dressing: development, characterization, and evaluation. Ferrante M, Alvarez VA, Gende LB, Guerrieri D, Chuluyan HE, Gonzalez JS. Colloid and Polymer Science 5/2024.
    3. Development of an efficient NUPR1 inhibitor with anticancer activity. Liu X, Jimenez-Alesanco A, Li Z, Rizzuti B, Neira JL, Estaras M, Peng L, Chuluyan E, Garona J, Gottardo F, Velazquez-Campoy A, Xia Y, Abian O, Santofimia-Castaño P, Iovanna J. Sci Rep. 2024 Nov 27;14(1):29515.
    4. Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity. Fraunhoffer NA, Abuelafia AM, Chanez B, Bigonnet M, Gayet O, Roques J, Chuluyan E, Dusetti N, Iovanna J. Cancer Commun (Lond). 2022 Nov;42(11):1212-1216.
    5. Human Endothelial Cell Seeding in Partially Decellularized Kidneys. Haeublein G, Lombardi G, Caro F, Guerrieri D, Remolins C, Incardona C, Casadei D, Chuluyan E. Biomed Res Int. 2022 Jul 13;2022:9018074.
    6. raft dysfunction in simultaneous pancreas kidney transplantation (SPK): Results of concurrent kidney and pancreas allograft biopsies. Uva PD, Papadimitriou JC, Drachenberg CB, Toniolo MF, Quevedo A, Dotta AC, Chuluyan E, Casadei DH. Am J Transplant. 2019 Feb;19(2):466-474. doi: 10.1111/ajt.15012.
    7. α-lipoic acid reduces postreperfusion syndrome in human liver transplantation – a pilot study. Casciato P, Ambrosi N, Caro F, Vazquez M, Müllen E, Gadano A, de Santibañes E, de Santibañes M, Zandomeni M, Chahdi M, Lazarte JC, Biagiola DA, Iaquinandi JC, Santofimia-Castaño P, Iovanna J, Incardona C, Chuluyan E. Transpl Int. 2018 Dec;31(12):1357-1368. doi: 10.1111/tri.13314.
    8. Targeting REG3β limits pancreatic ductal adenocarcinoma progression through CTGF downregulation. Fraunhoffer NA, Closa D, Folch-Puy E, Abuelafia AM, Calvo EL, Chuluyan E, Iovanna J. Cancer Lett. 2021 Aug 24;521:64-70.
    9. Squamousness gain defines pancreatic ductal adenocarcinoma hepatic metastases phenotype, and gemcitabine response. Fraunhoffer NA, Abuelafia AM, Teyssedou C, Chuluyan E, Bigonnet M, Palazzo L, Gayet O, Nicolle R, Cros J, Iovanna J, Dusetti N.Eur J Cancer. 2021 Sep;155:42-53.
    10. Secretory Leukocyte Proteinase Inhibitor Protects Acute Kidney Injury Through Immune and Non-Immune Pathways. Guerrieri D, Ambrosi NG, Romeo H, Salaberry J, Toniolo MF, Remolins C, Incardona C, Casadei D, Chuluyan E. Shock. 2021 Dec 1;56(6):1019-1027.
    11. Non-SARS-CoV-2 biomedical research in times of pandemic and post-pandemic. Remolins C, Chuluyan E. Medicina (B Aires). 2020;80(5):596-597. Long-term apoptosis-related protein expression in the diabetic mouse ovary.
    12. Fraunhoffer NA, Meilerman Abuelafia A, Aquino Barrientos M, Cimerman KV, Olmos MF, Chuluyan E, Barrios M.PLoS One. 2018 Sep 7;13(9):e0203268. doi:10.1371/journal.pone.0203268. eCollection 2018
    13. Alpha-1-antitrypsin ameliorates inflammation and neurodegeneration in the diabetic mouse retina.Ortiz G, Lopez ES, Salica JP, Potilinski C, Fernández Acquier M, Chuluyan E, Gallo JE.Exp Eye Res. 2018 Sep;174:29-39. doi:10.1016/j.exer.2018.05.013.
    14. Cementoin-SLPI fusion protein binds to human monocytes and epithelial cells and shows higher biological activity than SLPI.Maffía PC, Guerrieri D, Villalonga X, Caro F, Gómez S, Tateosian N, Bogado BP, Sánchez ML, Ambrosi N, Chuluyan E.Sci Rep. 2018 Mar 28;8(1):5332. doi: 10.1038/s41598-018-23680-0.
    15. Alpha Lipoic Acid: A Therapeutic Strategy that Tend to Limit the Action of Free Radicals in Transplantation.Ambrosi N, Guerrieri D, Caro F, Sanchez F, Haeublein G, Casadei D, Incardona C, Chuluyan E.Int J Mol Sci. 2018 Jan 4;19(1). pii:E102. doi: 10.3390/ijms19010102.
    16. Laparoscopic Biopsies in Pancreas Transplantation. Uva PD, Odorico JS, Giunippero A, Cabrera IC, Gallo A, Leon LR, Minue E, Toniolo F, Gonzalez I, Chuluyan E, Casadei DH.Am J Transplant. 2017 Aug;17(8):2173-2177. doi:10.1111/ajt.14259.
    17. Successfull Simultaneous Pancreas Kidney transplantation in a patient with Congenital Partial Lipodystrophy. Leon L, Uva P, Minue E, Pilotti R, Cabrera I, Giunippero A, Gallo A, Osella F, Toniolo F, Chuluyan E, Casadei D. Nefrologia. 2016 Jul-Aug;36(4):450-1. doi: 10.1016/j.nefro.2016.02.005.
    18. REG3β Plays a Key Role in IL17RA Protumoral Effect-Response. Loncle C, Bonjoch L, Folch-Puy E, Lopez-Millan MB, Lac S, Molejon MI, Chuluyan E, Cordelier P, Dubus P, Lomberk G, Urrutia R, Closa D, Iovanna JL. Cancer Res. 2016 Apr 1;76(7):2051. doi: 10.1158/0008-5472.CAN-15-3355.
    19. α-Lipoic Acid Protects Against Ischemia-Reperfusion Injury in Simultaneous Kidney-Pancreas Transplantation. Ambrosi N, Arrosagaray V, Guerrieri D, Uva PD, Petroni J, Herrera MB, Iovanna JL, León L, Incardona C, Chuluyan HE, Casadei DH. Transplantation. 2016 Apr;100(4):908-15. doi: 10.1097/TP.0000000000000981.
    20. IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer. Loncle C, Bonjoch L, Folch-Puy E, Lopez-Millan MB, Lac S, Molejon MI, Chuluyan E, Cordelier P, Dubus P, Lomberk G, Urrutia R, Closa D, Iovanna JL. Cancer Res. 2015 Nov15;75(22):4852-62. doi: 10.1158/0008-5472.CAN-15-0896.
    21. SPARC Controls Melanoma Cell Plasticity through Rac1. Salvatierra E, Alvarez MJ, Leishman CC, Rivas Baquero E, Lutzky VP, Chuluyan HE, Podhajcer OL. PLoS One.2015 Aug 6;10(8):e0134714. doi: 10.1371/journal.pone.0134714.
    22. A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérin-vaccinated Individuals. Peña D, Rovetta AI, Hernández Del Pino RE, Amiano NO, Pasquinelli V, Pellegrini JM, Tateosian NL, Rolandelli A, Gutierrez M, Musella RM, Palmero DJ, Gherardi MM, Iovanna J, Chuluyan HE, García VE. EBioMedicine. 2015 May 30;2(8):884-90.doi: 10.1016/j.ebiom.2015.05.026.
    23. Transglutaminase binding fusion protein linked to SLPI reduced corneal inflammation and neovascularization. Salica JP, Guerrieri D, Maffia P, Croxatto JO, Chuluyan HE, Gallo JE. BMC Ophthalmol. 2015 Feb 4;15:12. doi:10.1186/1471-2415-15-12.
    24. Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option? Ortiz G, Salica JP, Chuluyan EH, Gallo JE. Biol Res. 2014 Nov 18;47:58. doi:10.1186/0717-6287-47-58. Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells. Rosso M, Lapyckyj L, Amiano N, Besso MJ, Sánchez M, Chuluyan E, Vazquez-Levin MH. Biol Cell. 2014 Sep;106(9):308-22. doi:10.1111/boc.201300075.
    25. The impact of IFN-γ receptor on SLPI expression in active tuberculosis: association with disease severity. Tateosian NL, Pasquinelli V, Hernández Del Pino RE, Ambrosi N, Guerrieri D, Pedraza-Sánchez S, Santucci N, D’Attilio L, Pellegrini J, Araujo-Solis MA, Musella RM, Palmero DJ, Hernandez-Pando R, Garcia VE, Chuluyan HE. Am J Pathol. 2014 May;184(5):1268-73. doi:10.1016/j.ajpath.2014.01.006.
    26. Gene expression profile in delay graft function: inflammatory markers are associated with recipient and donor risk factors. Guerrieri D, Re L, Petroni J, Ambrosi N, Pilotti RE, Chuluyan HE, Casadei D, Incardona C.  Mediators Inflamm. 2014;2014:167361. doi: 10.1155/2014/167361.
    27. Anti-tumor effect of SLPI on mammary but not colon tumor growth. Amiano NO, Costa MJ, Reiteri RM, Payés C, Guerrieri D, Tateosian NL, Sánchez ML, Maffia PC, Diament M, Karas R, Orqueda A, Rizzo M, Alaniz L, Mazzolini G, Klein S, Sallenave JM, Chuluyan HE. J Cell Physiol. 2013 Feb;228(2):469-75. doi:10.1002/jcp.24153.
    28. IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. Jurado JO, Pasquinelli V, Alvarez IB, Peña D, Rovetta AI, Tateosian NL, Romeo HE, Musella RM, Palmero D, Chuluyán HE, García VE. J Leukoc Biol. 2012 Jun;91(6):991-1002. doi: 10.1189/jlb.1211619.
    29. Local and systemic cellular immunity in early renal artery atherosclerosis. Kotliar C, Juncos L, Inserra F, de Cavanagh EM, Chuluyan E, Aquino JB, Hita A, Navari C, Sánchez R. Clin J Am Soc Nephrol. 2012 Feb;7(2):224-30. doi:10.2215/CJN.06270611.
    30. Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model. Cicora F, Roberti J, Vasquez D, Guerrieri D, Lausada N, Cicora P, Palti G, Chuluyan E, Gonzalez P, Stringa P, Raimondi C. Clin Exp Immunol. 2012 Jan;167(1):169-77. doi: 10.1111/j.1365-2249.2011.04487.x.

LIBROS

    • Chuluyan E, Domingo Casadei. Compendio en inmunopatología en Trasplante renal. I. El rechazo humoral. ISBN: 978-987-45859-1-2. Editorial: Content Medicine. Buenos Aires, Argentina, Junio 2016.
    • Chuluyan E, Domingo Casadei. Compendio en inmunopatología en Trasplante renal. II. Las infecciones en los trasplantes renales. Editorial: Content Medicine. Buenos Aires, Argentina, Junio 2017.